HAMILTON, BERMUDA--(Marketwire - Jan 8, 2013) - Signet

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
HAMILTON, BERMUDA--(Marketwire - Jan 8, 2013) - Signet Jewelers Ltd ("Signet") (NYSE: SIG) (LSE: SIG), the largest specialty retail jeweler in the US and the UK, today announced its sales for the nine weeks ended December 29, 2012 ("Holiday Season") and guidance for the 14 weeks ending February 2, 2013 ("Fourth Quarter").       Same Store Sales   Ended December 29, 2012     9 weeks   48 weeks   Kay   up 5.8%   up 6.4%   Jared   up 4.8%   up 1.2%   Regional Brands   down 4.0%   down 3.2%   US Division   up 4.7%   up 3.9%   H.Samuel   down 0.5%   up 0.4%   Ernest Jones   down 5.5%   up 0.1%   UK division   down 2.6%   up 0.3%   Signet   up 3.3%   up 3.2%             Mike Barnes, Chief Executive Officer, commented: "We are pleased with our Holiday Season performance in both sales and margins. Same store sales were up 3.3%, led by the US division up 4.7%. We believe our strong performance was due to exceptional execution by our teams. I would like to thank them all very much for their dedication and hard work. We saw particularly strong performance in the weeks and days leading up to Christmas. Business trends continue to be encouraging in the US and have improved in the UK after the Holiday Season. During the Holiday Season in the US we experienced broad based strength across our merchandise offerings led by our initiatives in bridal, branded and exclusive merchandise, colored diamonds, fashion jewelry and watches. In the UK watches and branded jewelry were the strongest performers. Our performance is built on the long term competitive strengths of the business, including the great customer experience which our teams deliver, the strength of our merchandise, our continued investment in advertising to support our store concepts and merchandising initiatives, and our US customer finance programs, which are highly effective in supporting our customers' jewelry purchases. In addition, we are pleased with the pace and effectiveness of the Ultra Stores integration; and the results continue to be in-line with our expectations. We believe that Signet is well-positioned for Fiscal 2014 and we will remain focused on providing our customers with an outstanding experience, while continuing to invest in the business to further our competitive strengths and create shareholder value." Fiscal 2013 Guidance Update: Diluted earnings per share for the Fourth Quarter are currently projected at $2.05 to $2.10. Diluted earnings per share for the 53 weeks ending February 2, 2013 ("Fiscal 2013") are projected at $4.28 to $4.33. Capital spending for Fiscal 2013 is anticipated to be $138 million to $142 million reflecting current estimates of project timing. In addition to the Ultra Stores, Inc ("Ultra") acquisition, we anticipate 48 new US-based stores for the year. Sales Performance for the 9 Weeks ended December 29, 2012 In the nine week period ended December 29, 2012, total sales of $1,237.6 million, including $37.0 million of Ultra sales, increased 7.1% compared to an increase of 7.5% in the nine weeks ended December 31, 2011 ("the comparable nine weeks"). Same store sales increased 3.3% compared to 7.8% in the comparable nine weeks. Consolidated eCommerce sales increased by 39%, comprised of a 49% increase in the US division and an 8% increase in the UK division. In the nine week period ended December 29, 2012, the US division's total sales of $1,034.2 million, including $37.0 million of Ultra sales, increased 9.9% compared to an increase of 9.2% in the comparable nine weeks. Same store sales increased 4.7% led by both Kay and Jared compared to an increase of 9.2% in the comparable nine weeks. In the nine week period ended December 29, 2012, the UK division's total sales of $203.4 million decreased 5.0% compared to an increase of 0.9% in the comparable nine weeks. Same store sales in the UK were down 2.6% compared to an increase of 1.8% in the comparable nine weeks. The business strengthened late into the Holiday Season; however, it was insufficient to offset earlier traffic declines.               9 weeks ended December 29, 2012   Change from previous year         Same store sales   Non-same store sales, net1   Total sales at constant exchange rates2   Exchange translation impact2   Total sales as reported   Total sales as reported $million   Kay   5.8 %   1.7 %   7.5 %   -     7.5 %   $ 625.0   Jared   4.8 %   1.9 %   6.7 %   -     6.7 %   $ 291.7   Regional brands   (4.0 )%   40.5 %3   36.5 %3   -     36.5 %3   $ 117.53 US division   4.7 %   5.2 %   9.9 %   -     9.9 %   $ 1,034.2   H.Samuel   (0.5 )%   (5.3 )%   (5.8 )%   2.8 %   (3.0 )%   $ 120.7   Ernest Jones4   (5.5 )%   (5.8 )%   (11.3 )%   3.4 %   (7.9 )%   $ 82.7 UK division   (2.6 )%   (5.5 )%   (8.1 )%   3.1 %   (5.0 )%   $ 203.4 Signet   3.3 %   3.2 %   6.5 %   0.6 %   7.1 %   $ 1,237.6                                       __________ 1. Non-same store sales include all sales from stores not open for 12 months, as well as Ultra stores. 2. Non-GAAP measure. 3. Includes all stores selling under the Ultra nameplate. 4. Includes stores selling under the Leslie Davis nameplate. Sales Performance for the 48 Weeks ended December 29, 2012 In the 48 week period ended December 29, 2012, total sales of $3,707.7 million, including $37.0 million of Ultra sales, increased 4.4% compared to an increase of 9.6% in the 48 weeks ended December 31, 2011 ("the comparable 48 weeks"). Same store sales increased 3.2% compared to 9.4% in the comparable 48 weeks. Consolidated eCommerce sales increased by 37%, comprised of a 44% increase in the US division and a 14% increase in the UK division. In the 48 week period ended December 29, 2012, the US division's total sales of $3,063.2 million, including $37.0 million of Ultra sales, increased 6.2% compared to an increase of 11.0% in the comparable 48 weeks. Same store sales increased 3.9% compared to an increase of 11.6% in the comparable 48 weeks.  In the 48 week period ended December 29, 2012, the UK division's total sales of $644.5 million decreased 3.2% compared to an increase of 3.7% in the comparable 48 weeks. Same store sales in the UK were up 0.3% compared to an increase of 0.8% in the comparable 48 weeks.               48 weeks ended December 29, 2012   Change from previous year         Same store sales   Non-same store sales, net1   Total sales at constant exchange rates2   Exchange translation impact2   Total sales as reported   Total sales as reported $million   Kay   6.4 %   1.5 %   7.9 %   -     7.9 %   $ 1,833.4   Jared   1.2 %   1.6 %   2.8 %   -     2.8 %   $ 935.5   Regional brands   (3.2 )%   9.6 %3   6.4 %3   -     6.4 %3   $ 294.33 US division   3.9 %   2.3 %   6.2 %   -     6.2 %   $ 3,063.2   H.Samuel   0.4 %   (2.5 )%   (2.1 )%   (0.7 )%   (2.8 )%   $ 353.6   Ernest Jones4   0.1 %   (3.2 )%   (3.1 )%   (0.6 )%   (3.7 )%   $ 290.9 UK division   0.3 %   (2.9 )%   (2.6 )%   (0.6 )%   (3.2 )%   $ 644.5 Signet   3.2 %   1.3 %   4.5 %   (0.1 )%   4.4 %   $ 3,707.7                                       __________ 1. Non-same store sales include all sales from stores not open for 12 months, as well as Ultra stores. 2. Non-GAAP measure. 3. Includes all stores selling under the Ultra nameplate. 4. Includes stores selling under the Leslie Davis nameplate. Quarterly Dividend Reflecting the Board's confidence in the strength of the business, our ability to invest in growth initiatives, and the Board's commitment to building long term shareholder value, a quarterly cash dividend of $0.12 per Signet Common Share has been declared for the Fourth Quarter of Fiscal 2013, payable on February 27, 2013 to shareholders of record on January 28, 2013, with an ex-dividend date of January 24, 2013. Conference Call There will be a conference call today at 8.30 a.m. ET (1.30 p.m. GMT and 5.30 a.m. PT) and a simultaneous audio webcast and slide presentation available at www.signetjewelers.com. The slides are available to be downloaded from the website ahead of the conference call. To help ensure the conference call begins in a timely manner, all participants should dial in 5 to 10 minutes prior to the scheduled start time. The call details are:           US dial-in   +1 (646) 254 3360   Access code: 1424444 European dial-in   +44 (0)20 7136 2050   Access code: 1424444           A replay of the conference call and a transcript of the call will be posted on Signet's website as soon as is practical after the call has ended and will be available for one year.           Contact:   James Grant, VP - Investor Relations, Signet Jewelers   +1 (330) 668 5412 Press:   Alecia Pulman, ICR, Inc.   +1 (203) 682 8224           Investor Relations Program Details Signet will be taking part in the ICR XChange Conference on Wednesday, January 16, 2013 at the Fontainebleau Miami Beach, Miami Beach, Florida. Present will be Mike Barnes, Chief Executive Officer, Ronald Ristau, Chief Financial Officer and James Grant, Vice President - Investor Relations. The presentation, which is scheduled for 1:10 p.m. ET, will be webcast and available for replay on www.signetjewelers.com. About Signet Jewelers and Safe Harbor Statement Signet Jewelers is the largest specialty retail jeweler in the US and UK. Signet's US division operates over 1,400 stores in all 50 states primarily under the name brands of Kay Jewelers and Jared The Galleria Of Jewelry. Signet's UK division operates approximately 500 stores primarily under the name brands of H.Samuel and Ernest Jones. Further information on Signet is available at www.signetjewelers.com. See also www.kay.com, www.jared.com, www.hsamuel.co.uk and www.ernestjones.co.uk. This release contains statements which are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, based upon management's beliefs and expectations as well as on assumptions made by and data currently available to management, appear in a number of places throughout this release and include statements regarding, among other things, Signet's results of operation, financial condition, liquidity, prospects, growth, strategies and the industry in which Signet operates. The use of the words "expects," "intends," "anticipates," "estimates," "predicts," "believes," "should," "potential," "may," "forecast," "objective," "plan," or "target," and other similar expressions are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to a number of risks and uncertainties, including but not limited to general economic conditions, the merchandising, pricing and inventory policies followed by Signet, the reputation of Signet and its brands, the level of competition in the jewelry sector, the cost and availability of diamonds, gold and other precious metals, regulations relating to consumer credit, seasonality of Signet's business, financial market risks, deterioration in consumers' financial condition, exchange rate fluctuations, changes in consumer attitudes regarding jewelry, management of social, ethical and environmental risks, security breaches and other disruptions to Signet's information technology infrastructure and databases, inadequacy in and disruptions to internal controls and systems, changes in assumptions used in making accounting estimates relating to items such as extended service plans and pensions, and risks relating to Signet being a Bermuda corporation. For a discussion of these and other risks and uncertainties which could cause actual results to differ materially, see the "Risk Factors" section of Signet's Fiscal 2012 Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 22, 2012. Actual results may differ materially from those anticipated in such forward-looking statements. Signet undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances, except as required by law. Contact: James Grant VP - Investor Relations Signet Jewelers +1 (330) 668 5412 Press: Alecia Pulman ICR, Inc. +1 (203) 682 8224

View More
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Canada Navigates Operational Challenges Amid Storms

Updated Category News Views 205

Air Canada's Operational Challenges and Responses Air Canada has recently faced significant operational hurdles due to severe winter weather and an aircraft incident impacting its Toronto Pearson international hub. These challenges have necessitated a comprehensive update from the airline about its current status and ongoing recovery efforts. Recent Weather Impact on...

Continue Reading
Insight into Melexis' Ongoing Share Buy-Back Strategy

Updated Category News Views 128

Melexis Enhances Shareholder Value Through a Strategic Buyback Melexis, a leader in the semiconductor industry, has been actively engaging in a strategic share buy-back program aimed at bolstering shareholder value. This initiative, first announced on December 10, 2024, reflects the company's commitment to enhancing its stock's performance while also optimizing its...

Continue Reading
Value Line, Inc. Launches New Share Repurchase Initiative

Updated Category News Views 220

Value Line, Inc. Announces Stock Repurchase Program Value Line, Inc. (NASDAQ: VALU) recently revealed an exciting development for its shareholders: the Board of Directors has approved a share repurchase program that allows for the buyback of up to $2,000,000 worth of shares. This program comes into effect immediately and marks a significant move that replaces the previous...

Continue Reading
IsoEnergy Expands Stake in Premier American Uranium Inc. Assets

Updated Category News Views 154

IsoEnergy Enhances Investment in Premier American Uranium Inc. IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) has recently expanded its investment in Premier American Uranium Inc. by acquiring a significant number of common shares and warrants. This strategic move further establishes IsoEnergy’s commitment to capitalizing on the promising uranium market amid increasing...

Continue Reading
Texas Attorney General Takes Action Against Insulin Price Fixing

Updated Category News Views 70

Texas Attorney General's Lawsuit Against Insulin Price Fixing Texas Attorney General Ken Paxton has taken significant action by filing a lawsuit against several prominent insulin manufacturers and pharmacy benefit managers (PBMs). The lawsuit highlights allegations of a conspiracy to inflate insulin prices, affecting countless patients who rely on this vital medication....

Continue Reading